ProKidney Corp. (PROK)
NASDAQ: PROK · Real-Time Price · USD
1.830
+0.080 (4.57%)
At close: Jun 18, 2026, 4:00 PM EDT
1.810
-0.020 (-1.09%)
After-hours: Jun 18, 2026, 7:25 PM EDT
ProKidney Market Cap
ProKidney has a market cap or net worth of $552.77 million as of June 18, 2026. Its market cap has increased by 139.40% in one year.
Market Cap
552.77M
Enterprise Value
331.61M
1-Year Change
139.40%
Ranking
Category
Stock Price
$1.83
Market Cap Chart
Since June 30, 2021, ProKidney's market cap has increased from $258.80M to $552.77M, an increase of 113.59%. That is a compound annual growth rate of 16.50%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 18, 2026 | 552.80M | -17.97% |
| Dec 31, 2025 | 673.90M | 36.72% |
| Dec 31, 2024 | 492.90M | 17.61% |
| Dec 29, 2023 | 419.10M | -73.75% |
| Dec 30, 2022 | 1.60B | 405.76% |
| Dec 31, 2021 | 315.70M | 21.99% |
| Jun 30, 2021 | 258.80M | - |
View and export this data all the way back to 2021. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Ginkgo Bioworks Holdings | 599.03M |
| Crescent Biopharma | 587.82M |
| Prime Medicine | 583.39M |
| Gyre Therapeutics | 571.07M |
| Tectonic Therapeutic | 566.45M |
| MiMedx Group | 546.63M |
| AgomAb Therapeutics NV | 540.74M |
| XOMA Royalty | 525.34M |